BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25831728)

  • 1. [Reduction and withdrawal of chemotherapy].
    Yamaguchi S; Kato S
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():79-84. PubMed ID: 25831728
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatotoxicity of chemotherapy].
    Sato Y; Kato J
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():369-74. PubMed ID: 25831785
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cancer chemotherapy and anesthesia].
    Truffa-Bachi J; Jayr C; Poulain P; Droz JP
    Cah Anesthesiol; 1985; 33(1):11-20. PubMed ID: 2859919
    [No Abstract]   [Full Text] [Related]  

  • 4. L-Asparaginase-induced fulminating liver dysfunction.
    Okamura A; Nishimura M; Sanada Y; Yakushijin K; Matsuoka H; Yamamoto K; Minami H
    Int J Hematol; 2013 Jul; 98(1):6-7. PubMed ID: 23702916
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy Agents With Known Pulmonary Side Effects and Their Anesthetic and Critical Care Implications.
    Dana Oprea A
    J Cardiothorac Vasc Anesth; 2017 Dec; 31(6):2227-2235. PubMed ID: 26619953
    [No Abstract]   [Full Text] [Related]  

  • 6. Abdominal complications of chemotherapy: findings at computed tomography.
    Liu YI; Jha P; Wang ZJ; Yeh BM; Poder L; Westphalen AC; Coakley FV
    Clin Imaging; 2012; 36(1):54-60. PubMed ID: 22226444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late side effects of treatment: skeletal, genetic, central nervous system, and oncogenic.
    Jaffe N
    Pediatr Clin North Am; 1976 Feb; 23(1):233-44. PubMed ID: 768885
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiblastic chemotherapy in the presence of abdominal aorta aneurysm (AAA): guidelines.
    Lauro S; Lanzetta G; Bria E; Trasatti L; Gelibter A; Vecchione A
    Anticancer Res; 1999; 19(2B):1439-44. PubMed ID: 10365120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticancer drugs. Delayed toxicity].
    Rev Infirm; 2003 May; (91):22-3. PubMed ID: 12827755
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors.
    Salazar R; Cortés-Funes H; Casado E; Pardo B; López-Martín A; Cuadra C; Tabernero J; Coronado C; García M; Soto Matos-Pita A; Miguel-Lillo B; Cullell-Young M; Iglesias Dios JL; Paz-Ares L
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):75-83. PubMed ID: 23645288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lung diseases and chemotherapy in cancerology].
    Caubarrère I; Chebat J; Couderc LJ; Friand S; Stern M
    Pathol Biol (Paris); 1989 Feb; 37(2):165-6. PubMed ID: 2469056
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary toxicity of chemotherapy.
    Meadors M; Floyd J; Perry MC
    Semin Oncol; 2006 Feb; 33(1):98-105. PubMed ID: 16473648
    [No Abstract]   [Full Text] [Related]  

  • 13. Guidelines for handling antineoplastic and immunosuppressive drugs.
    Watson AD; Peaston AE; Malik R; Swinney GR
    Aust Vet J; 1997 Dec; 75(12):868-76. PubMed ID: 9469220
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatotoxicity of chemotherapy.
    Floyd J; Mirza I; Sachs B; Perry MC
    Semin Oncol; 2006 Feb; 33(1):50-67. PubMed ID: 16473644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineoplastic therapy-induced pulmonary toxicity.
    Sadowska AM; Specenier P; Germonpre P; Peeters M
    Expert Rev Anticancer Ther; 2013 Aug; 13(8):997-1006. PubMed ID: 23984900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative dose intensity: improving cancer treatment and outcomes.
    Lenhart C
    Oncol Nurs Forum; 2005 Jul; 32(4):757-64. PubMed ID: 15990905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailor chemotherapy education and equipment strategies based on risk and frequency.
    Wujcik DM
    ONS Connect; 2012 Apr; 27(4):7. PubMed ID: 22662583
    [No Abstract]   [Full Text] [Related]  

  • 18. Surviving malignant disease. Medical and oncological aspects.
    Price LA
    Br J Hosp Med; 1983 Jul; 30(1):8-12. PubMed ID: 6192863
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of the pulmonary toxicity of cancer chemotherapeutic agents.
    Weiss RB; Trush DM
    Oncol Nurs Forum; 1982; 9(1):16-21. PubMed ID: 6916364
    [No Abstract]   [Full Text] [Related]  

  • 20. September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents.
    Aapro MS; Link H
    Oncologist; 2008; 13 Suppl 3():33-6. PubMed ID: 18458123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.